Mark Scallon has more than 20 years’ experience working with clients in the life sciences industry to transform their compliance function.
Mark joined Baker Tilly in January 2020 as a principal in the life sciences practice. He has particular knowledge in compliance program development, process design, compliance auditing and monitoring, risk assessments, global spend transparency reporting, global investigations, privacy, pricing, and anti-bribery and corruption. Over the last 20+ years, Mark has assisted life science organizations with identifying existing and emerging compliance risks to develop practical solutions aligning company policies and procedures with industry practices, guidelines, regulations and laws.
Master of Health Administration (MHA)
Bachelor of Arts in english